| Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors PJ Therese, D Manvar, S Kondepudi, MB Battu, D Sriram, A Basu, ... Journal of chemical information and modeling 54 (2), 539-552, 2014 | 62 | 2014 |
| Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review VK Pulla, MB Battu, M Alvala, D Sriram, P Yogeeswari Expert opinion on therapeutic targets 16 (8), 819-832, 2012 | 41 | 2012 |
| Mycobacterium tuberculosis PPE2 protein interacts with p67phox and inhibits reactive oxygen species production S Srivastava, MB Battu, MZ Khan, VK Nandicoori, S Mukhopadhyay The Journal of Immunology 203 (5), 1218-1229, 2019 | 29 | 2019 |
| Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents SS Dinavahi, R Gowda, CG Bazewicz, MB Battu, JM Lin, RJ Chitren, ... European Journal of Medicinal Chemistry 187, 111962, 2020 | 28 | 2020 |
| Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport R Gowda, GS Inamdar, O Kuzu, SS Dinavahi, J Krzeminski, MB Battu, ... Oncotarget 8 (17), 28260, 2017 | 27 | 2017 |
| Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers HS Anantaraju, MB Battu, S Viswanadha, D Sriram, P Yogeeswari Molecular diversity 20, 521-535, 2016 | 24 | 2016 |
| Development of a novel multi-isoform ALDH inhibitor effective as an antimelanoma agent SS Dinavahi, R Gowda, K Gowda, CG Bazewicz, VR Chirasani, MB Battu, ... Molecular cancer therapeutics 19 (2), 447-459, 2020 | 21 | 2020 |
| PPE65 of M. tuberculosis regulate pro-inflammatory signalling through LRR domains of Toll like receptor-2 R Qureshi, NR Rameshwaram, MB Battu, S Mukhopadhyay Biochemical and biophysical research communications 508 (1), 152-158, 2019 | 12 | 2019 |
| Pharmacophore-based 3DQSAR and molecular docking studies to identify new non-peptidic inhibitors of cathepsin S MB Battu, AM Chandra, D Sriram, P Yogeeswari Current Medicinal Chemistry 21 (16), 1910-1921, 2014 | 11 | 2014 |
| Activating Sphingosine-1-phospahte signaling in endothelial cells increases myosin light chain phosphorylation to decrease endothelial permeability thereby inhibiting cancer … YC Chen, SS Dinavahi, Q Feng, R Gowda, S Ramisetti, X Xia, ... Cancer letters 506, 107-119, 2021 | 4 | 2021 |
| Antihypernociceptive effects of Petersianthus macrocarpus stem bark on neuropathic pain induced by chronic constriction injury in rats FDT Bomba, TB Nguelefack, G Matharasala, RK Mishra, MB Battu, ... Inflammopharmacology 29 (4), 1241-1253, 2021 | 2 | 2021 |
| Therapeutic application of PPE2 protein of Mycobacterium tuberculosis in inhibiting tissue inflammation R Pal, MB Battu, S Mukhopadhyay EMBO Molecular Medicine 14 (9), e14891, 2022 | 1 | 2022 |
| Therapeutic composition for inflammation/tissue injury S Mukhopadhyay, R Pal, MB Battu US Patent App. 16/737,012, 2020 | | 2020 |
| Design Synthesis and Pharmacological evaluation of novel Cathepsin S inhibitors MB Battu Pilani, 2014 | | 2014 |
